RobertS.RosensteinMD

PubMed

• 3 citations
  Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
  Brandon Cave, Augustus Hough, Robert Rosenstein> ;JACC. Cardiovascular Interventions. 2017 May 8
• 5 citations
  Ultrafiltration versus intravenous loop diuretics in patients with acute decompensated heart failure: a meta-analysis of clinical trials
  Mohamad Kabach, Hassan Alkhawam, Sachil Shah, Georges Joseph, Elie Donath, Noah Moss, Robert S. Rosenstein, Robert Chait> ;Acta Cardiologica. 2017 Feb 28
• Betrixaban in Acutely Ill Medical Patients.
  Cave, B., Hough, A., Rosenstein, R. S.> ;The New England journal of medicine. 2016 Dec 30
• 15 citations
  Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report.
  Robert Rosenstein, Jeffrey A. Bergsman, David Parra> ;Blood Coagulation & Fibrinolysis. 2015 Sep 1
• Neprilysin inhibition for heart failure.
  Hough A, Rosenstein R> ;N. Engl. J. Med.. 2014-12-11
• 23 citations
  Acute myocardial infarction during regadenoson myocardial perfusion imaging.
  Sachil Shah, Robert S. Rosenstein> ;Pharmacotherapy. 2013 Jun 1
• 1 citations
  Warfarin versus aspirin in heart failure and sinus rhythm.
  Sachil Shah, David Parra, Robert S. Rosenstein> ;The New England Journal of Medicine. 2012 Aug 23
• Dronedarone in high-risk permanent atrial fibrillation.
  Rosenstein R, Woods D> ;N. Engl. J. Med.. 2012-03-22
• 4 citations
  Letter by Reynolds et al Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation:...
  Stephanie Reynolds, Robert S. Rosenstein> ;Circulation. 2012 Jan 24
• 4 citations
  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
  Robert S. Rosenstein, David Parra> ;The New England Journal of Medicine. 2011 Dec 15
• Cardiac-resynchronization therapy.
  Rosenstein, R. S., Parra, D.> ;N Engl J Med. 2011 Mar 31
• 26 citations
  Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
  Kade Birkeland, Robert Rosenstein> ;Journal of Blood Medicine. 2010 Sep 1
• 16 citations
  “Effective” Plasma Renin Activity: A Derived Measure for Assessing Residual Plasma Renin Activity in Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiot...
  Jean E. Sealey, Robert S. Rosenstein, John H. Laragh> ;Hypertension. 2010 Mar 1
• Ticagrelor versus clopidogrel in acute coronary syndromes.
  Rosenstein, R. S., Parra, D.> ;N Engl J Med. 2009 Dec 10
• Biomarkers for prediction of cardiovascular events.
  Robert Rosenstein, David Parra> ;JAMA. 2009 Nov 18
• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
  Rosenstein, R., Parra, D.> ;Lancet. 2009 Jul 4
• Letter by Rosenstein and Parra Regarding Article, “Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellit...
  Robert S. Rosenstein, David Parra> ;Circulation. 2009 Jun 30
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
  Parra, D., Rosenstein, R.> ;N Engl J Med. 2009 Mar 12
• 1 citations
  Consistency in platelet morphology in whole blood.
  Robert Rosenstein> ;American Journal of Clinical Pathology. 1986 Apr 1
• 2 citations
  Drug-related changes in platelet shape in whole blood.
  Robert Rosenstein> ;Thrombosis Research. 1985 Sep 1
• 4 citations
  Substitution of tetramethylbenzidine for benzidine in cyanide analyses
  Kandace J. Williams, Robert Rosenstein, Roger P. Smith> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 1985 Jan 15
• 14 citations
  Cyanide prevents the inhibition of platelet aggregation by nitroprusside, hydroxylamine and azide.
  Francis T Schwerin, Robert Rosenstein, Roger P. Smith> ;Thrombosis and Haemostasis. 1983 Dec 30
• 8 citations
  Quantitation of human platelet transformation on siliconized glass: comparison of "normal' and "abnormal' platelets.
  Robert Rosenstein, Leo R. Zacharski, R D Allen> ;Thrombosis and Haemostasis. 1981 Aug 28
• 4 citations
  Tissue factor: a vitamin K-dependent clotting factor?
  Leo R. Zacharski, Robert Rosenstein, Philip G. Phillips> ;Annals of the New York Academy of Sciences. 1981 Jun 1
• 2 citations
  pH, PC02 and P02 in “High-volume” Platelet Concentrates Prepared by Discontinuous-flow Centrifugation and Stored in Polyvinylchloride and Polyethylene Containers
  Robert Rosenstein, John E. Lawe, Jane Gray North> ;American Journal of Clinical Pathology. 1980 Mar 1
• Join now to see all

Journal Articles

• Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation  
  Rosenstein R, Parra D, New England Journal of Medicine, 1/1/2011
• "Effective" Plasma Renin Activity: A Derived Measure for Assessing Residual Plasma Renin Activity in Patients Taking Angiotensin-converting Enzyme Inhibitors or Angiot...  
  Sealey JE, Parra D, Rosenstein R, Laragh JH, Hypertension, 1/1/2010
• Letter by Rosenstein and Parra regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy with Prasugrel in Patients with Diabetes Mellit...  
  Rosenstein RS, Circulation, 1/30/2009
• Bookends - The Reference Management System  
  Rosenstein RS, Physicians and Computers, 1/1/1985
• Procainamide-Induced Thrombocytopenia  
  Rosenstein RS, American Journal of Hematology, 1/1/1984
• Using a Data Base System to Document Procedural Competency  
  Rosenstein RS, Physicians and Computers, 1/1/1984
• Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension  
  Rosenstein RS, New England Journal of Medicine, 1/12/2009
• Ticagrelor versus Clopidogrel in Acute Coronary Syndromes  
  Rosenstein RS, Parra D, New England Journal of Medicine, 1/10/2009
• Cardiac-resynchronization Therapy  
  Rosenstein RS, Parra D, New England Journal of Medicine, 1/31/2011
• Predicting Bleeding Risk in Anticoagulated Patients with Atrial Fibrillation  
  Rosenstein R, DiMaggio E., Journal of the American College of Cardiology, 1/20/2011
• Antiplatelet Therapy in Acute Coronary Syndromes: Focus on Ticagrelor  
  Birkeland K, Parra D, Rosenstein R, Journal of Blood Medicine, 1/31/2010
• Risk of Bleeding with 2 Doses of Dabigatran Compared with Warfarin in Older and Younger Patients with Atrial Fibrillation: An Analysis of the Randomized Evaluation of ...  
  Reynolds S, Parra D, Rosenstein R, Circulation., 1/24/2012
• Dronedarone in High-risk Permanent Atrial Fibrillation  
  Rosenstein R, Woods D, New England Journal of Medicine, 1/22/2012
• Warfarin versus Aspirin in Heart Failure and Sinus Rhythm  
  Shah S, Parra D, Rosenstein R, New England Journal of Medicine, 1/23/2013
• Neprilysin Inhibition for Heart Failure  
  Hough A, Rosenstein R, New England Journal of Medicine, 1/11/2014
• Join now to see all

Lectures

• Update on Lipid Guidelines 
  1/1/2014
• Biomarkers 
  1/1/2009
• Regadenoson – ADVANCE 1 & 2 
  1/1/2009
• Tigacrelor – PLATO 
  1/1/2009
• ATHENA & ANDROMEDA – dronedarone 
  1/1/2009
• Onset-Offset -Ticagrelor 
  1/1/2009
• COURAGE Nuclear Substudy 
  1/1/2008
• Lp-PLA2 (Rancho Bernardo Study) 
  1/1/2008
• Fibrates 
  1/1/2008
• Perioperative Cardiovascular Evaluation 
  1/1/2008
• Stroke & Antiplatelet Therapy 
  1/1/2008
• JUPITER Trial 
  1/1/2008
• Statins in Aortic Valve Disease 
  1/1/2007
• COURAGE Trial 
  1/1/2007
• CHARISMA Subgroup Analysis 
  1/1/2007
• Rosiglitazone Meta-Analysis 
  1/1/2007
• Genomewide Association Analysis of CAD Disease 
  1/1/2007
• OASIS 5 
  1/1/2007
• The Updated Guidelines 2007 
  1/30/2008
• Acute Coronary Syndrome – Guidelines & Beyond 
  1/14/2009
• ACS/NSTEMI 
  1/20/2012
• TRITON TIMI 
  1/18/2007
• Join now to see all